Inefficacy of vancomycin and teicoplanin in eradicating and killing Staphylococcus epidermidis biofilms in vitro

International Journal of Antimicrobial Agents

Volumn 45, Issue 4, 2015, Pages 368-375

  Claessens, J ^a   Roriz, M ^a   Merckx, R ^a   Baatsen, P ^a   Van Mellaert, L ^b   Van Eldere, J ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Biofilm; Biofilm biomass; Killing efficacy; Staphylococcus epidermidis; Teicoplanin; Vancomycin

Indexed keywords

CRYSTAL VIOLET; GENTAMICIN; OXACILLIN; RIFAMPICIN; TEICOPLANIN; VANCOMYCIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL CELL; BACTERIAL CLEARANCE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BIOFILM; BIOMASS; CELL VIABILITY; DRUG EFFICACY; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; STAINING; STAPHYLOCOCCUS EPIDERMIDIS; DRUG EFFECTS; DRUG INTERACTION; GROWTH, DEVELOPMENT AND AGING; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL VIABILITY; MICROBIOLOGY; PHYSIOLOGY; STAPHYLOCOCCUS INFECTION;

ANTI-BACTERIAL AGENTS; BIOFILMS; DRUG INTERACTIONS; GENTAMICINS; HUMANS; MICROBIAL VIABILITY; OXACILLIN; RIFAMPIN; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS EPIDERMIDIS; TEICOPLANIN; VANCOMYCIN;

EID: 84925502721     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2014.11.011     Document Type: Article

References (30)

1. D. McDougald, S.A. Rice, N. Barraud, P.D. Steinberg, and S. Kjelleberg Should we stay or should we go: mechanisms and ecological consequences for biofilm dispersal Nat Rev Microbiol 10 2012 39 50
2. T. Bjarnsholt The role of bacterial biofilms in chronic infections APMIS Suppl 121 2013 1 51
3. Y. Yao, D.E. Sturdevant, and M. Otto Genomewide analysis of gene expression in Staphylococcus epidermidis biofilms: insights into the pathophysiology of S. epidermidis biofilms and the role of phenol-soluble modulins in formation of biofilms J Infect Dis 191 2005 289 298
4. P.S. Stewart Mechanisms of antibiotic resistance in bacterial biofilms Int J Med Microbiol 292 2002 107 113
5. N. Høiby, T. Bjarnsholt, M. Givskov, S. Molin, and O. Ciofu Antibiotic resistance of bacterial biofilms Int J Antimicrob Agents 35 2010 322 332
6. M.E. Skogman, P.M. Vuorela, and A. Fallarero Combining biofilm matrix measurements with biomass and viability assays in susceptibility assessments of antimicrobials against Staphylococcus aureus biofilms J Antibiot (Tokyo) 65 2012 453 459
7. Y. Qu, A.J. Daley, T.S. Istivan, D.A. Rouch, and M.A. Deighton Densely adherent growth mode, rather than extracellular polymer substance matrix build-up ability, contributes to high resistance of Staphylococcus epidermidis biofilms to antibiotics J Antimicrob Chemother 65 2010 1405 1411
8. N. Cerca, S. Martins, F. Cerca, K.K. Jefferson, G.B. Pier, and R. Oliveira Comparative assessment of antibiotic susceptibility of coagulase-negative staphylococci in biofilm versus planktonic culture as assessed by bacterial enumeration or rapid XTT colorimetry J Antimicrob Chemother 56 2005 331 336
9. S. Stepanović, D. Vuković, V. Hola, G. Di Bonaventura, S. Djukić, and I. Cirković Quantification of biofilm in microtiter plates: overview of testing conditions and practical recommendations for assessment of biofilm production by staphylococci APMIS 115 2007 891 899
10. C.Y. Hsu, M.H. Lin, C.C. Chen, S.C. Chien, Y.H. Cheng, and I.N. Su Vancomycin promotes the bacterial autolysis, release of extracellular DNA, and biofilm formation in vancomycin-non-susceptible Staphylococcus aureus FEMS Immunol Med Microbiol 63 2011 236 247
11. J.S. Cargill, and M. Upton Low concentrations of vancomycin stimulate biofilm formation in some clinical isolates of Staphylococcus epidermidis J Clin Pathol 62 2009 1112 1116
12. C.F. Batzilla, S. Rachid, S. Engelmann, M. Hecker, J. Hacker, and W. Ziebuhr Impact of the accessory gene regulatory system (Agr) on extracellular proteins, codY expression and amino acid metabolism in Staphylococcus epidermidis Proteomics 6 2006 3602 3613
13. D. Mack, N. Siemssen, and R. Laufs Parallel induction by glucose of adherence and a polysaccharide antigen specific for plastic-adherent Staphylococcus epidermidis: evidence for functional relation to intercellular adhesion Infect Immun 60 1992 2048 2057
14. E. Van Wijngaerden, W.E. Peetermans, J. Vandersmissen, S. Van Lierde, H. Bobbaers, and J. Van Eldere Foreign body infection: a new rat model for prophylaxis and treatment J Antimicrob Chemother 44 1999 669 674
15. S. Rachid, K. Ohlsen, W. Witte, J. Hacker, and W. Ziebuhr Effect of subinhibitory antibiotic concentrations on polysaccharide intercellular adhesin expression in biofilm-forming Staphylococcus epidermidis Antimicrob Agents Chemother 44 2000 3357 3363
16. European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by broth dilution Clin Microbiol Infect 9 2003 ix xv
17. D. Donati, and R. Biscaglia The use of antibiotic-impregnated cement in infected reconstructions after resection for bone tumours J Bone Joint Surg Br 80 1998 1045 1050
18. M. Monzón, C. Oteiza, J. Leiva, M. Lamata, and B. Amorena Biofilm testing of Staphylococcus epidermidis clinical isolates: low performance of vancomycin in relation to other antibiotics Diagn Microbiol Infect Dis 44 2002 319 324
19. D.J. Demczar, A.N. Nafziger, and J.S. Bertino Pharmacokinetics of gentamicin at traditional versus high doses: implications for once-daily aminoglycoside dosing Antimicrob Agents Chemother 41 1997 1115 1119
20. H. Yufang, Z. Zhaohui, Z. Huabin, L. Lijuan, and Y. Shouzhuo A sensitive and selective sensor-coated molecularly imprinted sol-gel film incorporating β-cyclodextrin-multi-walled carbon nanotubes and cobalt nanoparticles-chitosan for oxacillin determination Surf. Interface Anal. 44 2012 334 341
21. K. Toté, D. Vanden Berghe, M. Deschacht, K. de Wit, L. Maes, and P. Cos Inhibitory efficacy of various antibiotics on matrix and viable mass of Staphylococcus aureus and Pseudomonas aeruginosa biofilms Int J Antimicrob Agents 33 2009 525 531
22. T. Mathur, S. Singhal, S. Khan, D. Upadhyay, T. Fatma, and A. Rattan Adverse effect of staphylococci slime on in vitro activity of glycopeptides Jpn J Infect Dis 58 2005 353 357
23. R.O. Darouiche, A. Dhir, A.J. Miller, G.C. Landon, I.I. Raad, and D.M. Musher Vancomycin pepentration into biofilm covering infected prostheses and effect on bacteria J Infect Dis 170 1994 720 723
24. A.L.S. Antunes, J.W. Bonfanti, L.R.R. Perez, C.C. Pinto, A.L. Freitas, and A.J. Macedo High vancomycin resistance among biofilms produced by Staphylococcus species isolated from central venous catheters Mem Inst Oswaldo Cruz 106 2011 51 55
25. K. Udekwu, N. Parrish, P. Ankomah, F. Baquero, and B. Levin Functional relationship between bacterial cell density and the efficacy of antibiotics J Antimicrob Chemother 63 2009 745 757
26. R.F. Gagnon, G.K. Richards, and L. Wiesenfeld Staphylococcus epidermidis biofilms: unexpected outcome of double and triple antibiotic combinations with rifampin ASAIO Trans 37 1991 M158 M160
27. N.A. He, J. Hu, H.Y. Liu, T. Zhu, B. Huang, and X. Wang Enhancement of vancomycin activity against biofilms by using ultrasound-targeted microbubble destruction Antimicrob Agents Chemother 55 2011 5331 5337
28. Y. Aybar, R. Ozaras, K. Besirli, E. Engin, E. Karabulut, and T. Salihoglu Efficacy of tigecycline and vancomycin in experimental catheter-related Staphylococcus epidermidis infection: microbiological and electron microscopic analysis of biofilm Int J Antimicrob Agents 39 2012 338 342
29. Z.U. Isiklar, R.O. Darouiche, G.C. Landon, and T. Beck Efficacy of antibiotics alone for orthopaedic device related infections Clin Orthop Relat Res 332 1996 184 189
30. J.L. Del Pozo, M. García Cenoz, S. Hernáez, A. Martínez, A. Serrera, and A. Aguinaga Effectiveness of teicoplanin versis vancomycin lock therapy in the treatment of port-related coagulase-negative staphylococci bacteraemia: a prospective case-series analysis Int J Antimicrob Agents 34 2009 482 485